A preparation technology of volatile components in Linggui Zhugan decoction based on the transfer of cinnamaldehyde and its anti-gastric ulcer effect.

Ling Li, Nan Wang, Xiaolong Fan, Ning He, Tong Zhang
Author Information
  1. Ling Li: College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230000, China.
  2. Nan Wang: School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  3. Xiaolong Fan: School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  4. Ning He: College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230000, China.
  5. Tong Zhang: School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Abstract

Purpose: This study aims to preserve the volatile components of Linggui Zhugan (LGZG) decoction, offering an experimental foundation for subsequent preparations efforts.
Methods: Two modern sample preparation processes were compared with the traditional method approach using HPLC fingerprints. After identifying the main volatile components in LGZG aqueous decoction, the inclusion method of inclusion compounds (IC-LGZG) was established and optimized at laboratory, pilot and production scales. Characterization, stability testing of IC-LGZG, and experiments on gastric ulcer rats were conducted to validate the transferability of chemical composition and pharmaceutical efficacy.
Results: The study focused on preserving the volatile components in LGZG modern preparations. HPLC analysis revealed cinnamaldehyde (CA) as the main volatile component in LGZG decoction. The optimized IC-LGZG preparation involved heating aromatic water to 40 °C, adding 20 g/L of Cyclodextrin (CD), keeping warm and stirring at 300 r for 30 min. This process exhibited good repeatability across different verification tests at varying scales. IC-LGZG obtained effectively transferred CA molecules into the CD molecules via encapsulation, remaining stable when stored in sealed and dark conditions. Finally, CA, IC-LGZG and M-LGZG (a mixture of IC-LGZG and water-soluble extract powder) effectively prevented the formation of gastric ulcer by mitigating reductions in IL-10, SOD and the increase of TNF-α, NO, MDA in serum.
Conclusion: The IC-LGZG prepared using this process successfully transfers volatile components, both chemically and pharmacologically, making it suitable for modern preparations of LGZG.

Keywords

References

  1. J Pharm Pharmacol. 2020 Mar;72(3):319-342 [PMID: 31750548]
  2. Front Mol Biosci. 2023 Jul 07;10:1223621 [PMID: 37484528]
  3. J Ethnopharmacol. 2023 Dec 5;317:116747 [PMID: 37311500]
  4. Chem Biol Interact. 2023 Sep 1;382:110649 [PMID: 37499997]
  5. Int Immunopharmacol. 2023 May;118:110088 [PMID: 37011503]
  6. Biol Pharm Bull. 2015;38(1):109-15 [PMID: 25744466]
  7. J Ethnopharmacol. 2023 Jun 12;309:116338 [PMID: 36870462]
  8. Gastric Cancer. 2005;8(1):18-28 [PMID: 15747170]
  9. J Food Sci. 2019 Jun;84(6):1592-1599 [PMID: 31162880]
  10. Plants (Basel). 2023 Jun 30;12(13): [PMID: 37447078]
  11. Folia Histochem Cytobiol. 2020;58(4):264-271 [PMID: 33118610]
  12. Nan Fang Yi Ke Da Xue Xue Bao. 2006 Sep;26(9):1337-40 [PMID: 16982450]
  13. J Inflamm Res. 2022 Aug 16;15:4709-4723 [PMID: 35996682]
  14. Zhongguo Zhong Yao Za Zhi. 2016 Sep;41(18):3349-3354 [PMID: 28925116]
  15. J Cell Mol Med. 2022 Feb;26(3):913-924 [PMID: 34964259]
  16. J Pharm Biomed Anal. 2023 Feb 20;225:115223 [PMID: 36623427]
  17. J Biochem Mol Toxicol. 2021 May;35(5):e22730 [PMID: 33522063]
  18. Antioxidants (Basel). 2023 Jun 29;12(7): [PMID: 37507907]
  19. J Pharm Biomed Anal. 2022 Nov 30;221:115057 [PMID: 36126612]

Word Cloud

Created with Highcharts 10.0.0IC-LGZGvolatilecomponentsLGZGdecoctionulcerLingguiZhuganpreparationsmodernpreparationCAstudymethodusingHPLCmaininclusionoptimizedscalesgastriccinnamaldehydeCDprocesseffectivelymoleculesPurpose:aimspreserveofferingexperimentalfoundationsubsequenteffortsMethods:TwosampleprocessescomparedtraditionalapproachfingerprintsidentifyingaqueouscompoundsestablishedlaboratorypilotproductionCharacterizationstabilitytestingexperimentsratsconductedvalidatetransferabilitychemicalcompositionpharmaceuticalefficacyResults:focusedpreservinganalysisrevealedcomponentinvolvedheatingaromaticwater40 °Cadding20 g/LCyclodextrinkeepingwarmstirring300r30 minexhibitedgoodrepeatabilityacrossdifferentverificationtestsvaryingobtainedtransferredviaencapsulationremainingstablestoredsealeddarkconditionsFinallyM-LGZGmixturewater-solubleextractpowderpreventedformationmitigatingreductionsIL-10SODincreaseTNF-αNOMDAserumConclusion:preparedsuccessfullytransferschemicallypharmacologicallymakingsuitabletechnologybasedtransferanti-gastriceffectCinnamaldehydeGastricVolatileβ-cyclodextrin

Similar Articles

Cited By